Jasper Therapeutics (JSPR) Shares Outstanding (2019 - 2026)

Jasper Therapeutics has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $28.1 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 73.12% year-over-year to $28.1 million in Q2 2026; TTM through Jun 2026 was $28.1 million, a 73.12% increase from a year earlier, with the FY2025 full-year figure at $19.2 million, up 27.6% from the prior year.
• Shares Outstanding (Entity) was $28.1 million for Q2 2026 at Jasper Therapeutics, up from $19.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $28.1 million in Q2 2026, with the low at $3.8 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $12.5 million, with a median of $15.0 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) jumped 193.43% in 2023, then decreased 0.42% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $3.8 million in 2022, then surged by 193.43% to $11.2 million in 2023, then jumped by 34.56% to $15.0 million in 2024, then grew by 27.6% to $19.2 million in 2025, then surged by 46.49% to $28.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $28.1 million (Q2 2026), $19.2 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.